TLDR Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.
The study investigated the role of activator protein-1 (AP-1) in skin by using transgenic mice that conditionally express A-FOS, an inhibitor of AP-1. Older mice developed mild alopecia and sebaceous gland hyperplasia. During chemical-induced skin carcinogenesis, inhibiting AP-1 prevented typical squamous lesions and led to benign sebaceous adenomas with H-ras mutations. Inhibiting AP-1 in existing tumors caused squamous tumors to become sebaceous tumors, and reactivating AP-1 reversed this. Tumor cells expressed markers for both lineages, indicating multipotency. AP-1 was found to regulate the balance between wnt/β-catenin and hedgehog pathways, crucial for maintaining squamous tumor identity.
215 citations,
November 2000 in “Journal of Investigative Dermatology” The system allows precise control of gene expression in mouse skin, useful for studying skin biology.
33 citations,
March 1994 in “PubMed” High ODC and low K1 and K10 may indicate early skin tumors in mice.
Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.
16 citations,
July 2012 in “Current pharmaceutical biotechnology” New treatments for skin conditions related to the sebaceous gland are being developed based on current research.
13 citations,
September 2019 in “EBioMedicine” sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.
1533 citations,
October 2008 in “Endocrine reviews” Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.
159 citations,
July 2006 in “Endocrine Reviews” Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.
